0910-AC55 200904 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Positron Emission Tomography Drugs; Current Good Manufacturing Practices Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 212 PL 105-115, sec 121 Statutory Final 11/21/1999 No NPRM 09/20/2005 70 FR 55038 NPRM Comment Period End 12/19/2005 Final Action 08/00/2009 Yes Governmental Jurisdictions Federal State No No www.fda.gov/cder/regulatory/pet Yes No 0910-AB63 Previously reported as Michael Bernstein D. 0910 Food and Drug Administration FDA 301 796-3478 301 847-8440 michael.bernstein@fda.hhs.gov Center for Drug Evaluation and Research, Office of Regulatory Policy, 10903 New Hampshire Ave., Bldg. 51, Room 6240, Silver Spring MD 20993-0002